Cargando…
The results of Oxford unicompartmental knee arthroplasty in the United States: a mean ten-year survival analysis
AIMS: Approved by the Food and Drug Administration in 2004, the Phase III Oxford Medial Partial Knee is used to treat anteromedial osteoarthritis (AMOA) in patients with an intact anterior cruciate ligament. This unicompartmental knee arthroplasty (UKA) is relatively new in the United States, and th...
Autores principales: | Emerson, R. H., Alnachoukati, O., Barrington, J., Ennin, K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
British Editorial Society of Bone and Joint Surgery
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5047138/ https://www.ncbi.nlm.nih.gov/pubmed/27694514 http://dx.doi.org/10.1302/0301-620X.98B10.BJJ-2016-0480.R1 |
Ejemplares similares
-
Ten-year clinical and radiographic results of 1000 cementless Oxford unicompartmental knee replacements
por: Mohammad, Hasan R., et al.
Publicado: (2019) -
A structured evaluation of the symptomatic medial Oxford unicompartmental knee arthroplasty (UKA)
por: Janssen, Stein J., et al.
Publicado: (2021) -
Ten- to 15-year results of the Oxford
Phase III mobile unicompartmental knee arthroplasty: a prospective study from a non-designer group
por: Lisowski, L. A., et al.
Publicado: (2016) -
A survival analysis of 1084 knees of
the Oxford unicompartmental knee arthroplasty: a comparison between consultant and trainee surgeons
por: Bottomley, N., et al.
Publicado: (2016) -
Oxford Phase 3 unicompartmental knee arthroplasty: medium-term results of a minimally invasive surgical procedure
por: Lisowski, Lukas A., et al.
Publicado: (2010)